| Literature DB >> 35747199 |
Bao-Peng Liu1,2, Cun-Xian Jia1,2, Ping Qin3, Ying-Ying Zhang1,2, Yao-Kun Yu1,2, Xiao Luo1,2, Shi-Xue Li4.
Abstract
Background: Longitudinal evidence for sociodemographic and clinic factors deviating risk for suicide and repetition following SH (self-harm) varied greatly.Entities:
Keywords: Associating factors; CI, Confidence interval; Meta-analysis; NOS, Newcastle-Ottawa Scale; RR, Risk ratio; Repetition; SA, Suicide attempt; SC, Self-cutting; SH, Self-harm; SP, Self-poisoning; Self-harm; Suicide
Year: 2022 PMID: 35747199 PMCID: PMC9126760 DOI: 10.1016/j.eclinm.2022.101461
Source DB: PubMed Journal: EClinicalMedicine ISSN: 2589-5370
Figure 1The PRISMA flow diagram showing process of study selection for inclusion in our meta-analyses.
Characteristics of the included studies and assessment of risk of bias.
| First author (year of publishment) | Country or region | Follow-up time (Mean or Median or range) | Outcomes | Age range | Male (%) | Sample size | Included factors | Assessment of risk of bias using NOS |
|---|---|---|---|---|---|---|---|---|
| Definition of SH: SH | ||||||||
| Bergen (2010) | UK | 0–2 years | SH | Median: 30 years (IQR: 19 years) | 41.8 | 13,966 | Medium risk | |
| Bergen (2012) | UK | 3–11 years | Suicide | Median: 27 years (IQR: 19 years) | 35.0 | 30,202 | Low risk | |
| Bhaskaran (2014) | Canada | 0.5 years (At least 0.5 years for all cases) | SH | 18 years or above | 45.1 | 922 | Medium risk | |
| Bilen (2011) | Sweden | 0–3 years | SH | 18 years or above | 35.0 | 1524 | Medium risk | |
| Bilen (2014) | Sweden | 0.5 years (At least 0.5 years for all cases) | SH | 18 years or above | 28.3 | 325 | Medium risk | |
| Birtwistle (2017) | UK | Mean: 4.4 years | Suicide | 12 years or above | 42.0 | 6024 | Medium risk | |
| Chen (2013) | Taiwan, China | Mean:1.43 years | Suicide | 10–98 years | 29.4 | 3299 | Low risk | |
| Chen (2011) | Taiwan, China | Mean: 5.8 years | Suicide | 11–90 years | 36.3 | 1080 | Low risk | |
| Chen (2010) | Taiwan, China | Mean: 3.7 years | SH | 11–90 years | 37.0 | 970 | Medium risk | |
| Chung (2012) | Taiwan, China | 0–8 years | SH | All age groups but not identifying the range | 46.1 | 39,875 | Low risk | |
| Chung (2013) | Taiwan, China | 0–8 years | Suicide | 10 years or above | 43.5 | 3388 | Medium risk | |
| Corcoran (2015) | UK | 1 year (At least 1 year for all cases) | SH | All age groups but not identifying the range | 46.3 | 3337 | Medium risk | |
| Cully (2021) | Ireland | 0–1 year | SH | 18 years or above | 52.8 | 324 | Medium risk | |
| Hawton (2015) | UK | 2–13 years | Suicide | 7–97 years | 41.5 | 40,346 | High risk | |
| Kapur (2015) | UK | 0–1 years | Suicide | 10 years or above | 43.0 | 38,415 | Low risk | |
| Kawahara (2017) | Japan | 0–0.5 years | SH | 12–88 years | 29.9 | 405 | Medium risk | |
| Knipe (2019) | Sri Lanka | Median:1.9 years | SH | 10 years or above | 49.7 | 2259 | Medium risk | |
| Suicide | Medium risk | |||||||
| Kuo (2012) | Taiwan, China | Median: 3.3 years | Suicide | 15 years or above | 27.8 | 8343 | Low risk | |
| Kwok (2014) | Taiwan, China | Median: 1.4 years | SH | 15–96 years | 30.5 | 7601 | Medium risk | |
| Lindh (2018) | Sweden | 0.5 year (At least 1 year for all cases) | SH | 18–95 years | 33.0 | 804 | High risk | |
| Suicide | High risk | |||||||
| Madsen (2013) | Denmark | Mean: 4.2 years | Suicide | 18 years or above | 45.2 | 17,257 | Medium risk | |
| Miller (2013) | US | 0–5 years | SH | 15 years or above | 41.6 | 3600 | Low risk | |
| Suicide | Low risk | |||||||
| Olfson (2013) | US | 0.08 years | SH | 21–64 years | 31.8 | 5567 | Medium risk | |
| Olfson (2017) | US | 0–1 years | SH | 18–64 years | 33.0 | 61,054 | Medium risk | |
| Suicide | ||||||||
| Perry (2012) | Ireland | 0–1 years | SH | 10 years or above | Not available | 48,206 | Medium risk | |
| Riedi (2012) | France | 0.5 years (At least 0.5 years for all cases) | SH | Mean: 37.8 years (SD: 12.1 years) | 29.0 | 184 | High risk | |
| Runeson (2016) | Sweden | Mean: 5.3 years | Suicide | 10 years or above | 40.6 | 34,219 | Low risk | |
| Steeg (2018) | UK | 1 year (At least 1 years for all cases) | Suicide | 16 years or above | 42.0 | 31,715 | Low risk | |
| Thomas (2021) | US | 2 years | SH | 5 years or above | 37.0 | 9518 | Median risk | |
| Suicide | Low risk | |||||||
| Tidemalm (2015) | Sweden | 9–19 years | Suicide | 10 years or above | 42.4 | 53,843 | Low risk | |
| Vuagnat (2019) | France | 0–1 years | Suicide | 16 years or above | 37.2 | 136,451 | Medium risk | |
| Definition of SH: SA | ||||||||
| Aguglia (2020) | Italy | 0–0.5 years | SA | 18 years or above | 22.9 | 432 | Medium risk | |
| Chen (2016) | Taiwan, China | 0–3 years | SA | All age groups but not identifying the range | 33.0 | 51,579 | Medium risk | |
| Suicide | 25.0 | 6485 | Medium risk | |||||
| Chen (2013) | Taiwan, China | 0–0.5 years | SA | Mean: 38 years (SD: 15 years) | 31.6 | 1056 | Medium risk | |
| Chung (2021) | Taiwan, China | 0–16 years | SA | 10 years or above | 45.6 | 24,300 | Medium risk | |
| Demesmaeker | France | 0–1.17 years | SA | 18 years or above | 36.4 | 972 | Medium risk | |
| Espandian (2020) | Spain | 1 year (At least 1 year for all cases) | SA | 18 years or above | 25.7 | 319 | Medium risk | |
| Exbrayat (2017) | France | 1 year (At least 1 year for all cases) | SA | 18 years or above | 30.4 | 823 | Medium risk | |
| Fedyszyn (2016) | Denmark | 0–16 years | SA | All age groups but not identifying the range | Not available | 11,802 | Medium risk | |
| Suicide | Low risk | |||||||
| Fossi (2021) | France | 0.5 years | SA | Mean: 40.6 (SD: 15.0 years) | 41.3 | 10,666 | Medium risk | |
| Haglund (2016) | Sweden | 0.5 year (At least 0.5 year for all cases) | SA | 10–92 years | 37.5 | 355 | High risk | |
| Suicide | High risk | |||||||
| Huang (2014) | Taiwan, China | 1–6 years | SA | Mean: 40.5 years (SD:15.6 years) | 32.7 | 2070 | Medium risk | |
| Irigoyen (2019) | Spain | Mean: 1.7 years | SA | 18 years or above | 33.4 | 371 | Medium risk | |
| Johannessen (2011) | Norway | 0–5 years | SA | 15 years or above | 31.7 | 1304 | Medium risk | |
| 0–20 years | Suicide | Medium risk | ||||||
| Lipsicas (2014) | Multiple countries from Europe | 1 years (At least 1 years for all cases) | SA | Mean: 36.3 years (SD: 16.7 years) | 40.5 | 11,942 | Medium risk | |
| Liu (2022) | China | 0–10 years | Suicide | 15–70 years | 36.3 | 1103 | Low risk | |
| Mehlum (2010) | Norway | 0–5.5 years | SA | 18 years or above | 34.8 | 911 | Medium risk | |
| Monnin (2012) | France | 0–2 years | SA | 20 years or above | 30.8 | 273 | Medium risk | |
| O'Connor (2012) | UK | 2 years (At least 2 years for all cases) | SA | 16 years or above | 36.7 | 237 | Medium risk | |
| O'Connor (2017) | US | 0.5 years (At least 0.5 years for all cases) | SA | Mean: 37.3 years (SD: 10.54 years) | 54.0 | 160 | High risk | |
| Pan (2013) | Taiwan, China | Median: 1.4 years | Suicide | 15 years or above | 33.5 | 50,805 | Medium risk | |
| Parra-Uribe (2017) | Spain | 1 years (At least 1 years for all cases) | SA | Mean: 40.8 years (SD: 16.0 years) | 37.6 | 1241 | Medium risk | |
| Pavarin (2014) | Italy | 0–8.5 years | Suicide | Mean: 45.6 years | 39.4 | 505 | Low risk | |
| Runeson (2010) | Sweden | 21–31 years | Suicide | 10 years or above | 48.4 | 48,649 | Low risk | |
| Sawa (2017) | Japan | Mean: 3.7 years | SA | Mean: 39.8 years | 31.6 | 291 | Medium risk | |
| Wang (2015) | Taiwan, China | 1–6 years | Suicide | Mean:40.4 years (SD: 15.6 years) | 32.4 | 2052 | Medium risk | |
| Definition of SH: SC | ||||||||
| Carroll (2016) | UK | Mean: 2.1 years | Suicide | 14- 101 years | 41.1 | 3928 | Low risk | |
| Definition of SH: SP | ||||||||
| Finkelstein (2015) | Canada | Median: 5.3 years | Suicide | Median: 32 years (IQR:25 years) | 38.3 | 65,784 | Low risk | |
| Finkelstein (2016) | Canada | Median:4.3 years | SP | 10 years or above | 38.2 | 81,675 | Medium risk | |
| Pushpakumara (2019) | Sri Lanka | 0.08 years (At least 0.08 years for all cases) | SP | 10 years or above | 50.8 | 4022 | High risk | |
| Rajapakse (2016) | Sri Lanka | 1 years (At least 1 years for all cases) | SP | 14 years or above | 44.2 | 335 | High risk | |
SH: self-harm, SD: standard deviation, IQR: interquartile range, NOS: Newcastle-Ottawa Scale, SA: suicide attempt, SP: self-poisoning, SC: self-cutting.
Figure 2Characteristics, heterogeneity, and pooled estimates for sociodemographic and clinical factors associated with risk for SH repetition (No.: number, RR: risk ratio, CI: confidence interval. Horizontal line span 1 represented statistically significant. The reference for middle-aged adults and elderly was adolescent and young adults. Each line represented a pool estimate by meta-analysis.).
Figure 3Characteristics, heterogeneity, and pooled estimates for sociodemographic and clinical factors associated with risk for suicide following self-harm (No.: number, RR: risk ratio, CI: confidence interval, horizontal line span 1 represented statistically significant. The reference for middle-aged adults and elderly was adolescent and young adults. Each line represented a pool estimate by meta-analysis).
Subgroup analyses by the definition of self-harm.
| Associating factors | SH repetition | Suicide following SH | ||||||
|---|---|---|---|---|---|---|---|---|
| Definition of SH: SH/SP/SC | Definition of SH: SA | Definition of SH: SH/SP/SC | Definition of SH: SA | |||||
| n | RR (95%CI), I2 | n | RR (95%CI), I2 | n | RR (95%CI), I2 | n | RR (95%CI), I2 | |
| Middle-aged (Ref. adolescent and young adults) | 13 | 1.02 (0.94–1.10), 79.3% | 7 | 1.08 (0.85–1.36), 80.2% | 12 | 2.48 (1.84–3.35), 80.2% | 4 | 2.21 (1.55–3.16), 0 |
| Elderly (Ref. adolescent and young adults) | 11 | 0.74 (0.58–0.96), 72.7% | 7 | 0.56 (0.38–0.82), 83.0% | 11 | 4.05 (2.59–6.33), 80.8% | 4 | 5.69 (2.45–13.18), 57.3% |
| Gender | 19 | 1.07 (0.99–1.15), 75.3% | 20 | 1.15 (1.03–1.29), 83.1% | 17 | 2.08 (1.95–2.22), 26.6% | 9 | 1.72 (1.39–2.12), 69.3% |
| Single/divorced/separated/widowed | 4 | 1.19 (1.03–1.37), 30.0% | 8 | 1.09 (0.95–1.24), 27.5% | 2 | 0.97 (0.68–1.39), 47.4% | 3 | 1.03 (0.69–1.53). 0 |
| Unemployment | 3 | 1.06 (0.60–1.86), 63.3% | 9 | 1.09 (0.92–1.29), 44.1% | 3 | 1.08 (0.69–1.70), 68.3% | 1 | 2.11 (1.11–3.99), NA |
| Under high school | 2 | 1.08 (0.93–1.26), 0 | 3 | 0.96 (0.78–1.18), 0 | 2 | 0.73 (0.62–0.87), 0 | 1 | 0.79 (0.39–1.60), NA |
| Physical illness | 2 | 1.11 (0.98–1.25), 0 | 2 | 1.93 (0.64–5.87), 94.4% | 2 | 2.15 (1.36–3.40), 34.8% | 1 | 1.41 (0.50–3.99), NA |
| Multiple episodes of SH | 8 | 2.24 (1.58–3.19), 93.5% | 11 | 1.77 (1.14–2.74), 94.1% | 8 | 2.05 (1.57–2.66), 89.8% | 2 | 2.02 (0.74–5.50), 65.4% |
| Diagnosis of psychiatric disorder | 6 | 1.32 (0.99–1.75), 91.6% | 5 | 2.29 (1.38–3.81), 94.4% | 7 | 2.44 (1.83–3.25), 65.9% | 4 | 1.81 (1.33–2.45), 76.8% |
| Treatment of psychiatric disorder | 6 | 1.47 (1.30–1.66), 91.8% | 5 | 1.90 (1.30–2.78), 84.1% | 5 | 1.35 (1.19–1.53), 37.3% | 2 | 0.80 (0.16–4.12), 90.1% |
Male gender and female gender as the reference groups for suicide and repetition following self-harm, respectively.
SA: suicide attempt, SH: self-harm, SP: self-poisoning, SC: self-cutting, RR: risk ratio, CI: confidential interval.
n: The number of studies included in the subgroup analysis.
NA: I2 is not available when there was only one study included in the estimates.
Factors associated with heterogeneity assessed by meta-regression analysis.
| Associating factors | SH repetition, slope (P) | Suicide following self-harm, slope (P) | ||||||
|---|---|---|---|---|---|---|---|---|
| Adjusted model (Ref: crude model) | Long-term follow-up (Ref: short-term follow-up) | Sample size (ln) | SA as the definition of SH (Ref: SH/SP/SC) | Adjusted model (Ref: crude model) | Long-term follow-up (Ref: short-term follow-up) | Sample size (ln) | SA as the definition of SH (Ref: SH/SP/SC) | |
| Middle-aged (Ref. adolescent and young adults) | 0.034 (0.640) | −0.106 (0.113) | −0.074 (0.146) | 0.047 (0.585) | −0.436 (0.103) | 0.004 (0.990) | 0.317 (0.105) | −0.159 (0.622) |
| Elderly (Ref. adolescent and young adults) | −0.165 (0.565) | −0.380 (0.139) | −0.302 (0.192) | −0.507 (0.229) | 0.232 (0.462) | 0.342 (0.472) | ||
| Gender | 0.111 (0.084) | 0.066 (0.135) | 0.092 (0.148) | −0.012 (0.924) | −0.009 (0.941) | −0.050 (0.595) | ||
| Single/divorced/ | 0.150 (0.122) | 0.141 (0.195) | 0.044 (0.723) | −0.094 (0.361) | −0.247 (0.179) | −0.292 (0.326) | −0.223 (0.181) | 0.135 (0.535) |
| Unemployment | −0.181 (0.337) | −0.482 (0.062) | 0.127 (0.560) | −0.669 (0.192) | −0.863 (0.177) | 0.669 (0.192) | ||
| Under high school | −0.135 (0.337) | 0.007 (0.973) | −0.213 (0.621) | −0.118 (0.365) | 0.041 (0.875) | −0.076 (0.838) | −0.033 (0.890) | 0.076 (0.838) |
| Physical illness | 0.207 (0.763) | 0.474 (0.496) | 0.220 (0.588) | 0.493 (0.420) | −0.579 (0.203) | 0.848 (0.516) | −0.422 (0.500) | |
| Multiple episodes of SH | 0.304 (0.296) | −0.061 (0.842) | −0.235 (0.411) | 0.198 (0.473) | −0.159 (0.582) | 0.041 (0.831) | −0.088 (0.817) | |
| Diagnosis of psychiatric disorder | 0.076 (0.757) | 0.161 (0.543) | −0.142 (0.389) | 0.505 (0.059) | 0.408 (0.096) | 0.075 (0.778) | 0.245 (0.250) | −0.308 (0.151) |
| Mood disorder | 0.016 (0.906) | −0.028 (0.853) | 0.010 (0.894) | 0.029 (0.845) | 0.522 (0.242) | 0.249 (0.550) | 0.132 (0.739) | −0.059 (0.924) |
| Psychotic disorder | −0.345 (0.088) | −0.221 (0.381) | −0.205 (0.216) | −0.014 (0.955) | 1.001 (0.314) | −0.068 (0.944) | 0.456 (0.635) | 0.320 (0.810) |
| Substance use disorder | −0.140 (0.428) | 0.035 (0.840) | 0.343 (0.499) | −0.163 (0.778) | −0.045 (0.940) | |||
| Anxiety disorder | −0.379 (0.193) | −0.352 (0.169) | 0.440 (0.057) | |||||
| Personality disorder | 0.251 (0.350) | 0.069 (0.806) | −0.174 (0.536) | −0.090 (0.926) | 0.266 (0.804) | |||
| Adjustment disorder | −0.284 (0.716) | |||||||
| Treatment of psychiatric disorder | 0.035 (0.838) | −0.033 (0.793) | 0.245 (0.055) | 0.036 (0.886) | 0.018 (0.917) | 0.346 (0.183) | −0.089 (0.722) | |
| Psychiatric clinic | −0.286 (0.136) | −0.080 (0.740) | −0.067 (0.328) | 0.219 (0.194) | −0.219 (0.194) | 0.327 (0.386) | ||
| Psychiatric hospitalization | −0.228 (0.130) | −0.302 (0.319) | −0.207 (0.652) | 0.656 (0.109) | −0.207 (0.652) | |||
Male gender and female gender as the reference groups for suicide and repetition following self-harm, respectively.
Meta-regression was only performed when the number of included articles was above 3 records.
Only one category was found in the corresponding variable.
SA: suicide attempt, SH: self-harm, SP: self-poisoning, SC: self-cutting.